Rating Change
HC Wainwright & Co. reiterated its Buy rating on Assembly Biosciences, Inc. (NASDAQ:ASMB) on August 18, 2026.
reiterateNASDAQ:ASMB
HC Wainwright & Co. Reiterates Buy Rating on Assembly Biosciences, Inc. (ASMB)
HC Wainwright & Co. reiterated its Buy rating on Assembly Biosciences, Inc.
At publication ·
What changed
Assembly Biosciences, Inc. (NASDAQ:ASMB) · reiterate
- Firm
- HC Wainwright & Co.
- Rating
- Buy to Buy
- Price at event
- $32.13
- Market capitalization
- $257.0M
At a glance
Key takeaways
- HC Wainwright & Co. reiterated a Buy rating on Assembly Biosciences (ASMB) on August 18, 2026, with the stock trading at $32.13 and a market capitalization of $257.0 million.
- Among the 10 most recent analyst ratings, all 10 are Buy ratings with no Hold or Sell ratings, indicating unanimous positive sentiment from recent analyst coverage.
Market Context
Assembly Biosciences, Inc. operates in the Healthcare sector. The stock currently trades at $32.13 with a market capitalization of $257.0M.
Analyst coverage from HC Wainwright & Co. provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Assembly Biosciences, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Assembly Biosciences, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 18, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jun 15, 2026 | Mizuho | Outperform | N/A |
| May 28, 2026 | Guggenheim | Buy | N/A |
| May 04, 2026 | HC Wainwright & Co. | Buy | N/A |
| Apr 06, 2026 | Guggenheim | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View ASMB Stock Page
Frequently Asked Questions
What does the Buy rating mean for ASMB?
A rating of Buy from HC Wainwright & Co. reflects the analyst's outlook on Assembly Biosciences, Inc. (NASDAQ:ASMB). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the ASMB forecast page.